Abstract
Background
Lists of potentially inappropriate medications (PIM) in the elderly were developed in order to identify patients and/or drugs at risk of adverse drug reactions (ADRs) or inefficacy. However, the relationship between PIMs and ADRs remains discussed. We hypothesized that PIM use is associated with more ADRs than other prescriptions.
Methods
All ADRs registered by the Midi-Pyrénées PharmacoVigilance Center between the 1st January and the 30th June 2012 in patients ≥75 years were included. Data on patients (age, gender, Charlson comorbidity index), drugs (number, ATC classification, Laroche PIM classification) and ADRs (type, seriousness, mechanisms) were analyzed.
Results
Among the 923 ADRs recorded, 272 (29.5 %) were in patients ≥75 years. Mean age was 83.5 ± 5.5 years. Most of them (59 %) were females. Mean Charlson index was 5.6 ± 2.0 by ADR report. These 272 prescriptions involved 1,775 drugs [mean value, 6.5 (±3.4) drugs by ADR report] with 129 (7.3 %) PIM. Main PIM classes were nervous (n = 98, 76.0 %) and cardiovascular (17.8 %) drugs, including 32 atropinics (23.4 %). ADR-associated drugs were mainly antithrombotics, antibacterials, and analgesics for non-PIM drugs whereas PIM-associated ADRs were mainly observed with digoxine, psycholeptics, and psychoanaleptics. ADRs were mainly found with non-PIM drugs (89.3 %). Associated factors were the number of drugs for PIMs and the number of PIMs for PIM-induced ADRs.
Conclusion
Out of the ADR reports registered in the Midi-Pyrénées PharmacoVigilance Database for patients ≥75 years, 1 drug out of 12 is potentially inappropriate (mainly benzodiazepines, imipraminic antidepressants, and atropinic drugs). PIM use is not associated with more ADRs’ reports than other prescriptions.
Similar content being viewed by others
References
Merle L, Laroche ML, Dantoine T, Charmes JP (2005) Predicting and preventing adverse drug reactions in the very old. Drugs Aging 22:375–392
Tamblyn R (1996) Medication use in seniors: challenges and solutions. Therapie 51:269–282
Le Jeunne C, Hugues FC (1995) Drug interactions and the elderly. Therapie 50:247–252
Marcum ZA, Handler SM, Boyce R, Gellad W, Hanlon JT (2010) Medication misadventures in the elderly: a year in review. Am J Geriatr Pharmacother 8:77–83
Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151:1825–1832
Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157:1531–1536
Zuckerman IH, Hernandez JJ, Gruber-Baldini AL, Hebel JR, Stuart B, Zimmerman S, Magaziner J (2005) Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia. Am J Geriatr Pharmacother 3:246–254
Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, Schroll M, Onder G, Sørbye LW, Wagner C, Reissigová J, Bernabei R, AdHOC Project Research Group (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293:1348–1358
Fick D, Kolanowski A, Waller J (2007) High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period. Aging Ment Health 11:588–595
Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63:725–731
Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D (2008) STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 46:72–83
Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S (2010) Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord 24:56–63
Chang CB, Chen JH, Wen CJ, Kuo HK, Lu IS, Chiu LS, Wu SC, Chan DC (2011) Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol 72:482–489
Montastruc JL, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M, Bagheri H (2006) Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods. Joint Bone Spine 73:629–632
Montastruc F, Sommet A, Bondon-Guitton E, Durrieu G, Bui E, Bagheri H, Lapeyre-Mestre M, Schmitt L, Montastruc JL (2012) The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. Eur J Clin Pharmacol 68:767–775
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383
Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, Montastruc JL, Andrieu S, REAL.FR Group (2013) Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! Eur J Clin Pharmacol 69:1589–1597
Montastruc F, Laffont M, Bagheri H, Montastruc JL (2013) Potentially inappropriate medications in the elderly in France: a study in community pharmacies in 2011–2012. Eur J Clin Pharmacol 69:741–742
Imbs JL, Pouyanne P, Haramburu F, Welsch M, Decker N, Blayac JP, Bégaud B (1999) Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance. Therapie 54:21–27
Pouyanne P, Haramburu F, Imbs JL, Bégaud B (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. Br Med J 32:1036
Onder G, van der Cammen TJ, Petrovic M, Somers A, Rajkumar C (2013) Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing 42:284–291
Pretorius RW, Gataric G, Swedlund SK, Miller JR (2013) Reducing the risk of adverse drug events in older adults. Am Fam Physician 87:331–336
Lindley CM, Tully MP, Paramsothy V, Tallis RC (1992) Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 21:294–300
Lund BC, Carnahan RM, Egge JA, Chrischilles EA, Kaboli PJ (2010) Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 44:957–963
Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L (2007) Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 63:177–186
Budnitz DS, Lovegrove MC, Shehab N, Richards CL (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365:2002–2012
Price SD, Holman CD, Sanfilippo FM, Emery JD (2014) Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients. Ann Pharmacother 48:6–16
Begaud B, Martin K, Haramburu F, Moore N (2002) Rates of spontaneous reporting of adverse drug reactions in France. JAMA 288:1588
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Montastruc, F., Duguet, C., Rousseau, V. et al. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database. Eur J Clin Pharmacol 70, 1123–1127 (2014). https://doi.org/10.1007/s00228-014-1707-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-014-1707-9